跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA EFARMES 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA EFARMES 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA EFARMES 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Efarmes S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 9, 2020
Approval ID
cc1279cc7bd51e59
Company
Efarmes S.A.U.
Type
Standard
Approval Details
Approval Id
cc1279cc7bd51e59
Drug Cima Aemps Name
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA EFARMES 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85398
Holder Company Name
Efarmes S.A.U.
Marketing Company Name
Efarmes S.A.U.
Authorization Date
2020-09-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 MG/10 MG/25 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Efarmes S.A.U.
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
AMLODIPINO BESILATO
13,868 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 9, 2020
Approval ID
cc1279cc7bd51e59
Type
Standard
Back to CIMA-AEMPS Approvals